comprehensive -WSS

comprehensive

author：leisure time 2025-09-28 21:05:25 - browse：63

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Dog Aging Project founders on what lies ahead after losing funding

WSS

What causes osteoarthritis? Researchers study link to brain protein

Medicare bonuses could stop drug shortages under Senate plan

Diagnostic tests are hitting their mathematical limits

Flagship Pioneering launches a new biotech in two countries

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

HPV vaccine, cervical cancer study delivers historic results

hotspot

comprehensive

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

BIO selects John Crowley as new CEO

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

High breast density mammograms need follow

Psychedelics group wrestles with new pharma identity

What causes osteoarthritis? Researchers study link to brain protein

Supreme Court strikes down use of affirmative action

Rep. Raul Ruiz on the physician shortage and more

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The inclusion problem at the heart of rehabilitation research

hotspot

Pediatric cancer treatments threatened by a new FDA policy

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Inaction leaves children at risk from dangerous chemotherapy drug

TikTok, Instagram influencers need more rules for drug ads

Pediatric cancer treatments threatened by a new FDA policy

Medicare drug price lawsuits could be good politics for Biden

knowledge

focus

hotspot

knowledge